Arkolith/Insider Trading/ACAD/Form 4

Garofalo Elizabeth A.

DirectorACADIA PHARMACEUTICALS INC (ACAD) · full profile →Form 4 · filed Sep 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$42K
Net Open-Market Flow
-$42K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 2, 2025Sell(S)2K$25.98$42K25K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-023592) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML